Introduction

I
maging reporter gene expression with positron emission tomography (PET) is a growing field with many types of reporter genes/reporter probes under development and validation [1, 2] .
These approaches have major applications in gene/cell therapy, cell trafficking, transgenic models, and have recently entered clinical trials. One of the best validated reporter genes is the Herpes Simplex Virus Type 1 thymidine kinase (HSV1-tk), which can phosphorylate various substrates. A series of 5-substituted fluoroarabinofuranosyl nucleosides with high antiviral activity was first developed by Fox et al. in the late 1970s [3] [4] [5] [6] [7] . From these early studies, radiolabeled markers for HSV1-tk reporter gene expression and cell proliferation, such as 2′-deoxy-2′-fluoro-β-D-arabinofuranosyl-5-iodouracil ([ [10] [11] [12] [13] . We have also studied the use of the mutant HSV1-sr39tk reporter gene that was specifically engineered to prefer utilization of acycloguanosine derivatives over endogenous thymidine [14] .
Although [
F]FIAU and [
18 F]FHBG serve as good tracers for HSV1-tk reporter gene imaging, hepatic metabolism and clearance sometimes gives an undesired gastrointestinal background in the PET images, and therefore better substrates are still needed for some applications. We [8] and other groups [9, 15] All chemicals were purchased from Sigma-Aldrich (St. Louis, MO) unless otherwise specified and were used without further purification. Flash chromatography was carried out using silica gel 60 with a mesh of 70-230, 6 Å (Sigma-Aldrich). Thin-layer chromatography was performed using TLC-Silica gel 60W (Merck; Germany 
Preparation of 4 wt% Tetrabutylammonium Bicarbonate
Carbon dioxide from dry ice was bubbled into a 100-mL graduated cylinder containing tetrabutylammonium hydroxide (10 mL, 4% by weight in water) for 4 h at room temperature. The resulting tetrabutylammonium bicarbonate solution was stored at 0-5°C for use in the radiofluorination step. 
Synthesis of Precursors and Reference Standards
Triflic anhydride (0.65 mL, 3.8 mmol) was added to a solution of 1,3,5-tri-O-benzoylribofuranose 1 (1.76 g, 3.8 mmol) dissolved in anhydrous pyridine (8 mL) and stirred for 20 h at room temperature. The reaction mixture was poured into ice water (10 mL), and the product was extracted with dichloromethane (3×20 mL). The organic layer was washed with 10% HCl (2×10 mL) and saturated NaHCO 3 (2×10 mL). After drying the organic fraction over with MgSO 4 , the solvent was evaporated under vacuum. Crude triflate (1.97 g, 88%) was purified by column chromatography using 3:1 hexane and ethyl acetate as the eluent to afford 1.81 g (81%) of 2 as a colorless viscous oil. The reference standards for the [19] .
5 mmol) was dissolved in dichloromethane (20 mL). Diethyl amino sulfur trifluoride (1 mL) was added under nitrogen to the solution. The reaction was heated to 40°C overnight (~16 h). After cooling, the reaction was quenched with saturated sodium bicarbonate (10 mL). The organic layer was washed with brine (2×10 mL) and dried over MgSO 4 . Column chromatography with chloroform afforded pure fluoro product (0.65 g, 56%). The reference standards for the 
2-Deoxy
arabinofuranose 3a (140 mg, 3.1 μmol) was dissolved in anhydrous dichloromethane (3 mL). Hydrobromic acid in acetic acid (0.6 mL, 33 wt%) was added to the solution and stirred at room temperature overnight (~16 h). The solution was washed with saturated NaHCO 3 (3×3 mL) and dried over MgSO 4 . The solvent was removed in vacuo, and the residue (120 mg, 94.3%) was used in the next step without further purification. The reference standards for the 
2,4-Bis-O-(trimethylsilyl)-5-ethyluracil 6
Method A Hexamethyldisilazane (0.24 mL, 1.2 mmol) was added to a mixture of 5-ethyluracil 5 (140 mg, 1 mmol) and ammonium sulfate (13 mg, 0.1 mmol) in acetonitrile (5 mL). The reaction mixture was refluxed for 3 h, the solvent was removed in vacuo, and the product was used immediately in the next step [19, 21] .
Method B (for Radiochemistry)
Hexamethyldisilazane (0.2 ml, 0.96 μmol) was added to a 5-mL round-bottom flask containing 5-ethyluracil 5 (70 mg, 0.5 μmol), ammonium sulfate (6.6 mg, 0.05 μmol), and anhydrous acetonitrile (0.3 mL). The resulting mixture was heated under reflux for 2.5 h under argon. The reaction mixture was cooled and concentrated under reduced pressure to give a cloudy syrup. The residue was diluted with anhydrous acetonitrile (0.1 mL) and used for the subsequent step [19, 21] .
nosyl bromide (120 mg, 0.28 mmol) in chloroform (3 mL) was added to the solution, and the reaction mixture was refluxed for 24 h. After cooling to room temperature, the organic layer was washed with water (2×3 mL) and subsequently dried with Na 2 SO 4 . After the solvent was evaporated under vacuum, the white residue was dissolved in hot ethanol (~2 mL) and kept undisturbed at room temperature for 2 days to yield 106 mg (85.7%) of desired anomeric mixture as a white solid. [19, 21] .
1-(2′-Deoxy-2′-fluoro-D-arabinofuranosyl)-5-ethyl uracil 8a
and 8a′ The mixture of 7a and 7a′ (100 mg, 0.21 mmol) was dissolved in 2 M ammonia in methanol (2 ml), and the solution was stirred at room temperature overnight. The solvent was removed in vacuo, and FEAU was recrystallized with acetonitrile to give 8a/8a′ (49.8 mg, 89.6%). The reference standards for the 1 (33±8%; n=4) was eluted off the cartridge with ethyl acetate (3 mL) into a 5-mL conical vial and used directly in the next step. Product identity (t R =9.6 min) was confirmed by using analytical HPLC Method A [16, 18] . residue. The reaction mixture was sealed and heated to 100°C for 1 h. After the reaction was cooled with an ice bath, an aliquot (5 μL) was removed for HPLC analysis by Method A. The remaining mixture was loaded onto a silica gel Sep-pak plus cartridge, and the cartridge was eluted with 10% methanol in dichloromethane (3 mL). After coupled products were confirmed (α-anomer: t R =4.4 min; β-anomer: t R = 4.8 min) by standard coinjection, the anomeric [ 18 F]-7 mixture (83±6%; n=4) was not separated and used directly in the final deprotection step [16] . 18 F]-7 residue. The reaction mixture was sealed and heated to 100°C for 5 min. After the reaction was cooled with an ice bath, 1.0 N hydrochloric acid (0.25 mL) was added to quench the reaction, and the mixture was diluted with preparative HPLC mobile phase (2 mL). The crude mixture was reintroduced to the TRACERlab FX-FN module for HPLC separation using Preparative Method A to easily isolate pure β-anomer, [ 18 F]-8b, away from the α-form. The pure HPLC fraction was collected (t R = 16.5 min), subsequently processed by solid phase extraction using a C-18 Sep-pak plus cartridge, formulated with ethanol (1 mL) and 0.9% saline (9 mL), and sterile filtered with a Millex-MP filter (25 mm). HPLC analysis was performed on the formulated product using Method B for confirmed product identification (t R =7.0 min). Base hydrolysis steps and subsequent HPLC purification separated the anomeric mixture to afford purified [ 18 F]FEAU β-anomer in 5±1% overall yield (n=3 runs) after~5.5 h and a β/α-anomer ratio of 7.4. ]fluoride residue and heated to 160°C for 20 min. The reaction mixture was cooled, diluted with water (6 mL), and passed through a preconditioned C-18 Sep-pak plus cartridge. Another aliquot of water (6 mL) was used to rinse the reactor and wash the loaded C-18 cartridge. The trapped 18 F-radiolabeled intermediate was eluted off the cartridge with methanol (2 mL) back into the TRACERlab FX-FN reactor. Hydrochloric acid (1.0 N, 0.4 mL) was added to the reactor, and the mixture was heated to 105°C for 7 min. After cooling the reactor to 40°C, sodium hydroxide (1.0 N, 0.2 mL) and 50 mM ammonium acetate (NH 4 OAc) in ethanol (94:6 v/v, 2 mL) were added to neutralize and dilute the mixture for preparative HPLC purification. Purified [ 18 F]FHBG was isolated (t R =11.5 min) using Preparative Method B and passed through four preconditioned C-18 Sep-Pak plus cartridges connected in series. The loaded cartridges were eluted with 10% ethanol in 0.9% saline (5 mL), and the eluent was sterile filtered (Millex-GS; 33 mm; 0.2 μm) into a sterile multidose vial (30 mL) to give the final formulated product in 6±2% (n=69 runs). Product identity (t R =5.5 min) was confirmed by using analytical HPLC Method C [13] .
Synthesis of 9-[4-
Cell Culture and Uptake Studies
All the uptake studies were performed using rat glioma C6 cells (ATCC, Manassas, VA) cultured in high-glucose Dulbecco's modified Eagle's medium supplemented with 10% fetal bovine serum and 1% penicillin/streptomycin solution. Two stable clones of C6 cells expressing either HSV1-sr39 thymidine kinase (C6-sr39tk+) or a triple-fusion vector carrying a wild-type HSV1-thymidine kinase (C6-tk+) were utilized. C6, C6-tk+, and C6-sr39tk+ cells (5×10 5 ) were plated in 12 well dishes [23] . After 1 μCi) was added in each well and incubated at 37°C for 1 h. Cells were then washed three times with 1× phosphate-buffered saline and lysed in thymidine kinase lysis buffer, and the radioactivity of each well was counted in a Cobra II gamma counter (Perkin-Elmer). Protein concentration of the cell lysates were measured after the decay of radioactivity. All results were expressed as mean ± standard error (n=4) of counts per minute normalized to total protein (CPM/μg P). Selective indices were calculated as accumulation ratios between transfected cell and control cell to compare the selectivity to HSV1-tk or HSV1-sr39tk between probes.
Micro-PET imaging of [ 18 F]FHBG (~200 μCi/mouse) uptake. The micro-PET images were reconstructed with the ordered-subsets expectation maximization algorithm [24] and were analyzed by using a Medical Imaging Data Examiner (AMIDE) software [25] . The percentage-injected dose per gram (% ID/g) was calculated by dividing the region of interest counts by the injected dose (decay corrected) and reported as mean±standard error.
Statistical Analysis
Data are reported as mean ± standard error. A paired Student's t test was used to compare results across groups. A P value of less than 0.05 was considered statistically significant.
Results
The radiofluorination of 1 in the GE TRACERlab FX-FN synthesis module produced the radiolabeled intermediate 2 in moderate but reliable yields (33±8%; n=4) after purification using a silica gel Sep-Pak cartridge (Scheme 2). Purified intermediate 2 was transferred to a second custom module for the remaining reaction steps. Bromination of the purified material with 33% hydrobromic acid in acetic acid provided the bromo-derivative 3 in 85±8% (n=4) and was used directly in the next step after the solvent was removed by evaporation with toluene. Thymine bis-silyl derivative 5 was prepared in parallel to the initial two steps and immediately before the subsequent alkylation reaction which gave the coupled product in 83±6% yield (n=4). Deprotection of 5 using sodium methoxide afforded [ 18 F]FEAU as a mixture of α and β anomers. Special care and handling (i.e., maintaining inert environment and proper storage of sodium methoxide) of 5 and sodium methoxide were important in the success of making [
18 F]FEAU. HPLC purification of the anomeric mixture provided the β-anomer 8 (5±1% overall yield; n=3) after~5.5 h and revealed a β/α-anomer ratio of 7.4 after the completion of the multistep synthesis. Radiochemical/chemical purities (Fig. 2) and specific activity were greater than 99% and greater than 1.3 Ci/ μmol, respectively.
In (Fig. 3) . The selectivity index of both tracers is shown in Fig. 4 
Discussion
Many studies have been performed to develop optimized radiolabeled reporter probes for imaging HSV1-tk and HSV1- sr39tk reporter gene expression. Most of these studies have used stably transfected cell lines in cell culture and/or in xenograft models to compare the efficiency between pyrimidine nucleoside and acycloguanosine derivatives, while some have used adenoviral-mediated gene delivery [26] . Pyrimidine nucleoside derivatives such as FIAU not only show higher cell uptake than acycloguanosine analogues such as fluoropencyclovir (PCV) or FHBG in HSV1-tk stably transfected cells but also show higher uptake in nontransfected tumor cells as compared to acycloguanosines [27] .
Because of a similar structure to natural thymidine, FIAU has been used for imaging HSV1-tk reporter gene expression [28] [29] [30] [31] [32] . However, FIAU is not suitable for antiviral therapeutic applications because FIAU is severely toxic to mitochondria in normal cells and fatally toxic to neurons and liver in clinical studies. Another 5-substituted nucleoside, FEAU, was also developed as an anti-Herpes Simplex agent [33, 34] FEAU demonstrated lower cellular toxicity but is still as effective as FIAU to treat cells infected with Herpes Simplex Virus. We [8] and others [35] 18 F-labeled arabinofuranosyl nucleosides [16, 17] . In the current study, we examined these routes and developed methods for synthesizing [ 18 F] FEAU with both commercial and custom-made radiochemistry modules in our laboratory. Furthermore, we studied [ Mutant HSV1-tk's were initially developed to more effectively utilize acyclovir and ganciclovir (GCV) and to less effectively utilize thymidine to allow for more effective suicide gene therapy [36] . We have attempted to improve the sensitivity of imaging reporter gene expression by using an alternate substrate such as GCV, PCV, and FHBG and the mutant reporter gene HSV1-sr39tk [14] . It is interesting to Fig. 5 (A and B) ]FHBG/HSV1-sr39tk as this depends on the exact levels of the reporter enzyme in each cell line studied. Furthermore, we did not study effects of viral delivery of reporter as compared to stable expression of the reporter, and this may also affect results as we have previously reported [27] .
To be a good candidate for in vivo imaging, the reporter probe needs to have not only high sensitivity and selectivity for HSV1-tk/sr39tk but also favorable in vivo pharmacokinetic profiles. The lipophilic FHBG reveals both hepatobiliary and renal excretion pathways, sometimes making it harder to interpret reporter gene expression in the abdominal/ pelvic areas. Future studies will need to look at accumulation in additional cell lines, effects of extracellular thymidine on uptake, and studies in living subjects with both tumor models and adenoviral/lentiviral-mediated gene delivery.
Conclusion
The routine radiosynthesis of [ 18 F]FEAU was successfully semiautomated using a commercial module along with customized equipment to provide the β-anomer in modest yields. Although further studies are needed, early results in cells and living mice suggest [
18 F]FEAU is a promising PET radiotracer for monitoring HSV1-tk reporter gene expression in living subjects.
